• Our Company

    A Heritage of Improving Lives Through Innovation

    History Timeline Top Banner
    O

    ur company’s legacy of innovation began in 1858, when our founders made it their mission to bring better health solutions to patients?who?needed them most. Today, we are?continuing that tradition by?using?the latest science and technology to help improve?lives through the research and development of new medicines for serious diseases.? See our timeline below for select historical events.

    The Journey Begins

    EA4C17
    EDWARD ROBINSON SQUIBB

    1845

    EDWARD ROBINSON SQUIBB
    EDWARD ROBINSON SQUIBB

    Dr.?Squibb?graduates?from Philadelphia’s Jefferson Medical College. He spends?a decade as a surgeon in the U.S.?Navy, an experience that impresses?upon him the urgent need?for high-quality, standardized medicines.?

    1858

    FIRST LABORATORY

    Dr. Squibb rents a?brownstone?in Brooklyn, New York,?for his new business and begins pharmaceutical manufacturing operations. In December, he?is?severely burned in an?ether fire that nearly destroys his business.

    1858

    FIRST LABORATORY
    FIRST LABORATORY

    Dr. Squibb rents a?brownstone?in Brooklyn, New York,?for his new business and begins pharmaceutical manufacturing operations. In December, he?is?severely burned in an?ether fire that nearly destroys his business.

    SQUIBB MEDICINE CHEST

    1861–1865

    SQUIBB MEDICINE CHEST
    SQUIBB MEDICINE CHEST

    During the Civil War,?Squibb manufactures compact,?portable chests?for military surgeons that?contain?an?array of medicines and?equipment—from ether and morphine to?bandages and sponges. Each?chest?costs?about $100, the equivalent of several thousand dollars today.?

    ?

    ?

    1879

    DR. SQUIBB’S PROPOSAL FOR SAFE MEDICINE

    Dr. Squibb presents a report to the?New York?State Medical Society, “Proposed Law to Prevent the Adulteration of Food and Medicine and to?Create?a State Board of Health.”?Known as?the Squibb Bill, it?becomes law and serves as the basis for the Federal Pure Food and Drug Act of 1906.?

    1879

    DR. SQUIBB’S PROPOSAL FOR SAFE MEDICINE
    DR. SQUIBB’S PROPOSAL FOR SAFE MEDICINE

    Dr. Squibb presents a report to the?New York?State Medical Society, “Proposed Law to Prevent the Adulteration of Food and Medicine and to?Create?a State Board of Health.”?Known as?the Squibb Bill, it?becomes law and serves as the basis for the Federal Pure Food and Drug Act of 1906.?

    CLINTON PHARMACEUTICALS

    1887

    CLINTON PHARMACEUTICALS
    CLINTON PHARMACEUTICALS

    William?Bristol and John Myers invest?$5,000 to purchase the failing Clinton Pharmaceutical Company. With a pledge to sell no?“quack remedies,” the two quickly turn?the business around.

    1892

    E.R. SQUIBB & SONS FORMED

    Dr. Squibb forms a partnership with his?sons, Edward and Charles, and the firm is renamed E.R Squibb?&?Sons.?The company has capital?assets of?$1.5 million, according to the Articles of Incorporation filed in 1895.?

    1892

    E.R. SQUIBB & SONS FORMED
    E.R. SQUIBB & SONS FORMED

    Dr. Squibb forms a partnership with his?sons, Edward and Charles, and the firm is renamed E.R Squibb?&?Sons.?The company has capital?assets of?$1.5 million, according to the Articles of Incorporation filed in 1895.?

    FIRST BREAKTHROUGH PRODUCT

    1898

    FIRST BREAKTHROUGH PRODUCT

    Marketed as a tonic and laxative, Sal Hepatica salts, dubbed the “poor man’s spa,” mimic the taste and effect of the natural mineral waters of a Bohemian spa. Within a decade, annual sales rise to a half-million dollars. The product is a mainstay of Bristol Myers until 1974.?

    1898

    FIRST BREAKTHROUGH PRODUCT
    FIRST BREAKTHROUGH PRODUCT

    Marketed as a tonic and laxative, Sal Hepatica salts, dubbed the “poor man’s spa,” mimic the taste and effect of the natural mineral waters of a Bohemian spa. Within a decade, annual sales rise to a half-million dollars. The product is a mainstay of Bristol Myers until 1974.?

    BRISTOL, MYERS COMPANY

    1899

    BRISTOL, MYERS COMPANY
    BRISTOL, MYERS COMPANY

    Bristol and Myers rename their business the Bristol, Myers Company, which outgrows its home in Clinton, New York. The company relocates — first to Syracuse and then, in 1899, to Brooklyn to better serve customers in New England and Pennsylvania.

    IPANA

    1901

    IPANA

    Bristol Myers?introduces?Ipana?toothpaste,?featuring a disinfectant to prevent tooth decay and gum disease.?

    1901

    IPANA
    IPANA

    Bristol Myers?introduces?Ipana?toothpaste,?featuring a disinfectant to prevent tooth decay and gum disease.?

    1902

    SQUIBB QUALITY-CONTROL LABORATORY

    E.R. Squibb & Sons establishes its first quality-control laboratory. Soon, it has nearly 100 employees and produces over 800 preparations.?

    1902

    SQUIBB QUALITY-CONTROL LABORATORY
    SQUIBB QUALITY-CONTROL LABORATORY

    E.R. Squibb & Sons establishes its first quality-control laboratory. Soon, it has nearly 100 employees and produces over 800 preparations.?

    NEW JERSEY PLANT

    1905

    NEW JERSEY PLANT
    NEW JERSEY PLANT

    E.R.?Squibb?&?Sons?purchases an ether manufacturing plant in what was then the wilds of New Brunswick,?New Jersey.?

    1906

    PURE FOOD AND DRUG ACT

    President Theodore Roosevelt signs the Pure Food and Drug Act of 1906?into law.?Although Dr. Squibb died in 1900, the act is a?triumph of?his?lifelong?crusade?for safe, reliable pharmaceutical products.?

    GROWING IN NEW JERSEY

    Bristol Myers?purchases seven acres in Hillside, New Jersey,?for expanded production of?Sal Hepatica.?

    1906

    PURE FOOD AND DRUG ACT
    PURE FOOD AND DRUG ACT

    President Theodore Roosevelt signs the Pure Food and Drug Act of 1906?into law.?Although Dr. Squibb died in 1900, the act is a?triumph of?his?lifelong?crusade?for safe, reliable pharmaceutical products.?

    GROWING IN NEW JERSEY

    Bristol Myers?purchases seven acres in Hillside, New Jersey,?for expanded production of?Sal Hepatica.?

    DIGITALIS

    1917

    DIGITALIS

    E.R.?Squibb?&?Sons?pioneers the?standardization of digitalis, derived?from the foxglove plant as an early treatment for heart conditions.

    1917

    DIGITALIS
    DIGITALIS

    E.R.?Squibb?&?Sons?pioneers the?standardization of digitalis, derived?from the foxglove plant as an early treatment for heart conditions.

    BRISTOL MYERS GOES PUBLIC

    1929

    BRISTOL MYERS GOES PUBLIC
    BRISTOL MYERS GOES PUBLIC

    Gross profits top $1 million and?the company’s?products are sold in 26 countries.?Bristol Myers?becomes a publicly held?firm?on the New York Stock Exchange.?

    1938

    SQUIBB INSTITUTE FOR MEDICAL RESEARCH

    Squibb furthered its commitment to innovative research by opening the 52,000-square foot Squibb Institute for Medical Research in New Brunswick, New Jersey.

    1938

    SQUIBB INSTITUTE FOR MEDICAL RESEARCH
    SQUIBB INSTITUTE FOR MEDICAL RESEARCH

    Squibb furthered its commitment to innovative research by opening the 52,000-square foot Squibb Institute for Medical Research in New Brunswick, New Jersey.

    INTOCOSTRIN

    1939

    INTOCOSTRIN

    Squibb researchers?develop a new method for preparing curare and provide free samples of Intocostrin to clinical researchers, who find the curare extract helpful in relaxing the muscles of surgical patients.

    1939

    INTOCOSTRIN
    INTOCOSTRIN

    Squibb researchers?develop a new method for preparing curare and provide free samples of Intocostrin to clinical researchers, who find the curare extract helpful in relaxing the muscles of surgical patients.

    CHEPLIN BIOLOGICAL LABORATORIES

    1943

    CHEPLIN BIOLOGICAL LABORATORIES
    CHEPLIN BIOLOGICAL LABORATORIES?

    Bristol Myers?acquires?Cheplin?Laboratories in Syracuse,?New York, enabling it?to mass produce penicillin?during World War II. This marks?the company’s entry into ethical drug development.?

    1944

    PENICILLIN PRODUCTION PLANT

    Squibb opens the world’s largest penicillin production facility in New Brunswick, New Jersey.

    1944

    PENICILLIN PRODUCTION PLANT
    PENICILLIN PRODUCTION PLANT

    Squibb opens the world’s largest penicillin production facility in New Brunswick, New Jersey.

    FLO-CILLIN ‘96’

    1948

    FLO-CILLIN ‘96’

    Bristol Laboratories introduces Flo-Cillin 96, a long-lasting injectable penicillin.

    NEW PAIN RELIEVER

    Bufferin is also introduced.

    1948

    FLO-CILLIN ‘96’
    FLO-CILLIN ‘96’

    Bristol Laboratories introduces Flo-Cillin 96, a long-lasting injectable penicillin.

    NEW PAIN RELIEVER

    Bufferin is also introduced.

    SQUIBB RECEIVES THE LASKER AWARD

    1955

    SQUIBB RECEIVES THE LASKER AWARD

    The company receives one of the most respected science prizes in the world for discovering anti-tubercular properties for an antibiotic used to treat tuberculosis.

    1955

    SQUIBB RECEIVES THE LASKER AWARD
    SQUIBB RECEIVES THE LASKER AWARD

    The company receives one of the most respected science prizes in the world for discovering anti-tubercular properties for an antibiotic used to treat tuberculosis.

    EARLY CANCER RESEARCH

    1956

    EARLY CANCER RESEARCH
    EARLY CANCER RESEARCH

    Bristol Myers Squibb enters the cancer drug development field, building on collaborations around promising antibiotics with the Microbial Chemistry Research Foundation of Japan.

    1959

    CLAIROL PURCHASED

    Bristol Myers acquires the hair-coloring company Clairol, which was founded in 1931 by Joan and Lawrence M. Gelb. Their son, Richard L. Gelb, would later serve as Bristol Myers’ president, CEO and Chairman of the Board.

    1959

    CLAIROL PURCHASED
    CLAIROL PURCHASED

    Bristol Myers acquires the hair-coloring company Clairol, which was founded in 1931 by Joan and Lawrence M. Gelb. Their son, Richard L. Gelb, would later serve as Bristol Myers’ president, CEO and Chairman of the Board.

    NEW LABORATORY

    1966

    NEW LABORATORY
    NEW LABORATORY

    Ground is broken for the construction of Bristol Myers Products research and development laboratories in Hillside, New Jersey. It is the largest proprietary laboratory in the world.

    1967

    MEAD JOHNSON & COMPANY

    Bristol Myers Squibb acquires Mead Johnson. At the time, Mead-Johnson produces the only comprehensive line of infant feeding needs.

    1967

    MEAD JOHNSON & COMPANY
    MEAD JOHNSON & COMPANY

    Bristol Myers Squibb acquires Mead Johnson. At the time, Mead-Johnson produces the only comprehensive line of infant feeding needs.

    1967

    Anti-Cancer Treatment

    Squibb researchers develop the company’s first anti-cancer treatment.?

    1967

    Anti-Cancer Treatment

    Squibb researchers develop the company’s first anti-cancer treatment.?

    SQUIBB HEADQUARTERS ESTABLISHED

    1971

    SQUIBB HEADQUARTERS ESTABLISHED
    SQUIBB HEADQUARTERS ESTABLISHED

    Squibb establishes worldwide headquarters in Princeton, New Jersey, and expands facilities for the Squibb Institute for Medical Research. This allows Squibb to make more groundbreaking discoveries and advancements.

    1972

    PALOMAR PICTURES INTERNATIONAL

    Bristol Myers announces the formation of Palomar Pictures International. Palomar produces several films, including The Stepford Wives and The Taking of Pelham One Two Three. The company exits the film business two years later.

    1972

    PALOMAR PICTURES INTERNATIONAL
    PALOMAR PICTURES INTERNATIONAL

    Bristol Myers announces the formation of Palomar Pictures International. Palomar produces several films, including The Stepford Wives and The Taking of Pelham One Two Three. The company exits the film business two years later.

    1973

    PRODUCT APPROVAL

    FDA approves?MUTAMYCIN??(mytomycin).?

    1973

    PRODUCT APPROVAL

    FDA approves?MUTAMYCIN??(mytomycin).?

    1974

    PRODUCT APPROVAL

    FDA approves?BLENOXANE??(bleomycin?sulfate).?

    1974

    PRODUCT APPROVAL

    FDA approves?BLENOXANE??(bleomycin?sulfate).?

    1975

    PRODUCT APPROVAL

    FDA approves?CAPOTEN??(captopril).?

    1975

    PRODUCT APPROVAL

    FDA approves?CAPOTEN??(captopril).?

    1976

    PRODUCT APPROVAL

    FDA approves?CeeNU??(lomustine)?and BICNU??(carmustine).?

    1976

    PRODUCT APPROVAL

    FDA approves?CeeNU??(lomustine)?and BICNU??(carmustine).?

    CREATION OF CONVATEC

    1978

    CREATION OF CONVATEC
    CREATION OF CONVATEC

    ConvaTec is formed by Squibb to market ostomy and wound therapy products.

    1979

    PRODUCT APPROVAL

    PLATINOL? (cisplatin)?becomes the first platinum-containing anti-cancer drug for testicular cancer.?

    1979

    PRODUCT APPROVAL

    PLATINOL? (cisplatin)?becomes the first platinum-containing anti-cancer drug for testicular cancer.?

    1983

    PRODUCT APPROVAL

    The FDA approves VEPESID??(etoposide).?

    1983

    PRODUCT APPROVAL

    The FDA approves VEPESID??(etoposide).?

    BRISTOL MYERS RESEARCH COMPLEX OPENS

    1986

    BRISTOL MYERS RESEARCH COMPLEX OPENS

    Bristol Myers?opens?a state-of-the-art research complex in?Wallingford,?Connecticut, housing?more than 800 scientists and support?staff. In 1995, it?is named the Richard L. Gelb Center for Pharmaceutical Research and Development after the former chairman and CEO.?

    1986

    BRISTOL MYERS RESEARCH COMPLEX OPENS
    BRISTOL MYERS RESEARCH COMPLEX OPENS

    Bristol Myers?opens?a state-of-the-art research complex in?Wallingford,?Connecticut, housing?more than 800 scientists and support?staff. In 1995, it?is named the Richard L. Gelb Center for Pharmaceutical Research and Development after the former chairman and CEO.?

    1986

    PRODUCT APPROVAL

    BUSPAR, discovered by Bristol Myers neuroscience researchers, is approved for the treatment of generalized anxiety disorder.

    1986

    PRODUCT APPROVAL

    BUSPAR, discovered by Bristol Myers neuroscience researchers, is approved for the treatment of generalized anxiety disorder.

    1989

    BRISTOL MYERS AND SQUIBB MERGE

    Bristol Myers merges with Squibb, creating a global leader in the health care industry. The merger creates Bristol Myers Squibb, the world’s second-largest pharmaceutical enterprise. One of the first medicines the new company introduces is PARAPLATIN, approved for treating recurrent ovarian cancer.

    1989

    BRISTOL MYERS AND SQUIBB MERGE
    BRISTOL MYERS AND SQUIBB MERGE

    Bristol Myers merges with Squibb, creating a global leader in the health care industry. The merger creates Bristol Myers Squibb, the world’s second-largest pharmaceutical enterprise. One of the first medicines the new company introduces is PARAPLATIN, approved for treating recurrent ovarian cancer.

    BRISTOL MYERS SQUIBB FOUNDATION ESTABLISHED

    1990

    BRISTOL MYERS SQUIBB FOUNDATION ESTABLISHED
    BRISTOL MYERS SQUIBB FOUNDATION ESTABLISHED

    Inspired by the Bristol Myers Fund established in 1953, the Bristol Myers Squibb Foundation is created to promote health equity and improve health outcomes of populations disproportionately affected by serious diseases. Through its work around the globe, the Foundation focuses on strengthening health care worker capacity, integrating medical care and community-based supportive services, and mobilizing communities in the fight against disease.

    1991

    Product Approval

    1991

    Product Approval

    1997

    RESEARCH CAMPUS OPENS

    Bristol Myers Squibb?opens?a 433-acre research campus in?Hopewell,?New Jersey.??

    1997

    RESEARCH CAMPUS OPENS
    RESEARCH CAMPUS OPENS

    Bristol Myers Squibb?opens?a 433-acre research campus in?Hopewell,?New Jersey.??

    1997

    PRODUCT APPROVAL?

    1997

    PRODUCT APPROVAL?
    NATIONAL MEDAL OF TECHNOLOGY

    1998

    NATIONAL MEDAL OF TECHNOLOGY
    NATIONAL MEDAL OF TECHNOLOGY

    President Bill Clinton awards?the National Medal of Technology — America’s highest honor for technological innovation — to?Bristol Myers Squibb "for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study through groundbreaking and hugely complex clinical trials that are recognized models in the industry."?

    1999

    SECURE THE FUTURE INITIATIVE ANNOUNCED

    The?Bristol Myers Squibb?Foundation?announces?SECURE THE FUTURE?,?a?$100 million commitment to advance HIV/AIDS research and community outreach programs in seven African countries: Botswana, Namibia, Lesotho, Swaziland, Uganda, Burkina Faso and Tanzania.?

    1999

    SECURE THE FUTURE INITIATIVE ANNOUNCED
    SECURE THE FUTURE INITIATIVE ANNOUNCED

    The?Bristol Myers Squibb?Foundation?announces?SECURE THE FUTURE?,?a?$100 million commitment to advance HIV/AIDS research and community outreach programs in seven African countries: Botswana, Namibia, Lesotho, Swaziland, Uganda, Burkina Faso and Tanzania.?

    CHILDREN’S HOSPITAL OPENS

    2001

    CHILDREN’S HOSPITAL OPENS
    CHILDREN’S HOSPITAL OPENS

    The Bristol Myers Squibb Children’s Hospital opens?as part of Robert Wood Johnson University Hospital in New Brunswick,?New Jersey. The first freestanding children’s hospital in?the state,?it?offers?care without regard to?a?family’s ability to pay and offers?more than 45 pediatric specialties.

    DUPONT PHARMACEUTICALS?PURCHASED?

    DuPont pharmaceuticals is acquired, strengthening?Bristol Myers Squibb’s HIV and cardiovascular businesses while also adding medical imaging.?

    2001

    PRODUCT ACQUISITION???

    2002

    PRODUCT APPROVAL

    FDA approves ABILIFY??(aripiprazole).?

    2002

    PRODUCT APPROVAL

    FDA approves ABILIFY??(aripiprazole).?

    2003

    PRODUCT APPROVAL

    FDA approves REYATAZ??(atazanavir).

    2003

    PRODUCT APPROVAL

    2004

    PRODUCT APPROVAL

    2004

    PRODUCT APPROVAL
    CLINICAL CENTER FOR CHILDREN WITH HIV/AIDS

    2007

    CLINICAL CENTER FOR CHILDREN WITH HIV/AIDS OPENS

    The?clinical center at the Bristol Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital in New Brunswick,?New Jersey,?is dedicated to the research and treatment of children’s immune system disorders and infectious diseases. The Bristol Myers Squibb Pediatric Infectious?Disease and Immunology Center is made possible by a $5 million gift from the Bristol Myers Squibb Foundation.

    2007

    CLINICAL CENTER FOR CHILDREN WITH HIV/AIDS
    CLINICAL CENTER FOR CHILDREN WITH HIV/AIDS OPENS

    The?clinical center at the Bristol Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital in New Brunswick,?New Jersey,?is dedicated to the research and treatment of children’s immune system disorders and infectious diseases. The Bristol Myers Squibb Pediatric Infectious?Disease and Immunology Center is made possible by a $5 million gift from the Bristol Myers Squibb Foundation.

    2007

    PRODUCT APPROVAL

    FDA approves IXEMPRA? (ixabepilone).

    2007

    PRODUCT APPROVAL

    FDA approves IXEMPRA? (ixabepilone).

    2009

    BRISTOL MYERS SQUIBB ACQUIRES MEDAREX

    Bristol Myers Squibb acquires Medarex, Inc., a biotech company and a partner since 2005. The acquisition significantly expands the company’s oncology and immunology pipeline.

    2009

    BRISTOL MYERS SQUIBB ACQUIRES MEDAREX
    BRISTOL MYERS SQUIBB ACQUIRES MEDAREX

    Bristol Myers Squibb acquires Medarex, Inc., a biotech company and a partner since 2005. The acquisition significantly expands the company’s oncology and immunology pipeline.

    2009

    PRODUCT APPROVAL

    FDA approves ONGLYZA? (saxagliptin).

    2009

    PRODUCT APPROVAL

    FDA approves ONGLYZA? (saxagliptin).

    2010

    PRODUCT APPROVAL

    FDA approves KOMBIGLYZE? XR (saxagliptin and metformin HCl extended‐release).

    2010

    PRODUCT APPROVAL

    FDA approves KOMBIGLYZE? XR (saxagliptin and metformin HCl extended‐release).

    INVESTING IN THE FUTURE

    2013

    INVESTING IN THE FUTURE
    INVESTING IN THE FUTURE

    To expand its capabilities in development and manufacturing of biologics, the company announces a $250 million expansion of its manufacturing complex in Devens, Massachusetts.

    EXPANSION CONTINUES

    2014

    EXPANSION CONTINUES

    Construction begins on a new, large-scale biologics manufacturing facility in Cruiserath, Ireland, to be built on the grounds of its existing bulk pharmaceutical manufacturing plant.

    A new state-of-the-art office campus is planned for Lawrenceville, New Jersey, to replace leased facilities in Plainsboro and West Windsor.?

    2014

    EXPANSION CONTINUES
    EXPANSION CONTINUES

    Construction begins on a new, large-scale biologics manufacturing facility in Cruiserath, Ireland, to be built on the grounds of its existing bulk pharmaceutical manufacturing plant.

    A new state-of-the-art office campus is planned for Lawrenceville, New Jersey, to replace leased facilities in Plainsboro and West Windsor.?

    2014

    Product Approval

    FDA approves OPDIVO??(nivolumab).

    2014

    Product Approval

    2015

    BRISTOL MYERS SQUIBB NAMED A LEADING SUSTAINABLE COMPANY

    Bristol Myers Squibb is recognized as one of Dow Jones’ North America Index of Leading Sustainable Companies. Its efforts to promote economic, social and environmental sustainability are core to the mission and reflect its ongoing commitment to patients, employees and partners, the environment and communities around the world.

    Bristol Myers Squibb Foundation Celebrates?60th?Anniversary?

    The Bristol Myers Squibb Foundation marks a quarter of a century helping millions of people across the world overcome serious diseases.?

    2015

    BRISTOL MYERS SQUIBB NAMED A LEADING SUSTAINABLE COMPANY
    BRISTOL MYERS SQUIBB NAMED A LEADING SUSTAINABLE COMPANY

    Bristol Myers Squibb is recognized as one of Dow Jones’ North America Index of Leading Sustainable Companies. Its efforts to promote economic, social and environmental sustainability are core to the mission and reflect its ongoing commitment to patients, employees and partners, the environment and communities around the world.

    Bristol Myers Squibb Foundation Celebrates?60th?Anniversary?

    The Bristol Myers Squibb Foundation marks a quarter of a century helping millions of people across the world overcome serious diseases.?

    2015

    PRODUCT APPROVAL

    2015

    PRODUCT APPROVAL
    PRINCETON PIKE CAMPUS OPENS

    2016

    PRINCETON PIKE CAMPUS OPENS
    PRINCETON PIKE CAMPUS OPENS

    This state-of-the-art campus in New Jersey features work space designed to foster greater innovation, productivity and collaboration.?

    PRIX GALIEN AWARD

    Bristol Myers Squibb?is awarded the Prix Galien U.S. “Discovery of the Decade.”?This is the third Prix Galien honor that?the company?has received, after being recognized for “Best Biotechnology Product” in 2012 and “Best Biotechnology Product” in 2015.?

    2017

    BRISTOL MYERS SQUIBB CELEBRATES?130TH?ANNIVERSARY?

    Chairman and CEO Giovanni Caforio rings the New York Stock Exchange’s Closing Bell in celebration of the company milestone.

    2017

    BRISTOL MYERS SQUIBB CELEBRATES 130TH ANNIVERSARY
    BRISTOL MYERS SQUIBB CELEBRATES?130TH?ANNIVERSARY?

    Chairman and CEO Giovanni Caforio rings the New York Stock Exchange’s Closing Bell in celebration of the company milestone.

    BRISTOL MYERS SQUIBB ACQUIRES CELGENE

    2019

    BRISTOL MYERS SQUIBB ACQUIRES CELGENE

    Bristol Myers Squibb and Celgene come together to create a leading biopharma company positioned to address the needs of patients with serious diseases.

    2019

    BRISTOL MYERS SQUIBB ACQUIRES CELGENE
    BRISTOL MYERS SQUIBB ACQUIRES CELGENE

    Bristol Myers Squibb and Celgene come together to create a leading biopharma company positioned to address the needs of patients with serious diseases.

    超级碰碰色偷偷免费视频